MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
47.52
+0.23 (0.49%)
At close: Jun 27, 2025, 4:00 PM
46.60
-0.92 (-1.94%)
After-hours: Jun 27, 2025, 4:39 PM EDT
MLTX Market Cap
MLTX has a market cap or net worth of $3.02 billion as of June 27, 2025. Its market cap has increased by 14.33% in one year.
Market Cap
3.02B
Enterprise Value
2.61B
1-Year Change
14.33%
Ranking
Category
Stock Price
$47.52
Market Cap Chart
Since February 14, 2022, MLTX's market cap has increased from $3.60M to $3.02B, an increase of 83,730.75%. That is a compound annual growth rate of 639.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 3.00B | -12.10% |
| Dec 31, 2024 | 3.41B | -5.66% |
| Dec 29, 2023 | 3.62B | 784.47% |
| Dec 30, 2022 | 409.26M | 11,274.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 696.15B |
| Johnson & Johnson | 366.71B |
| AbbVie | 322.03B |
| Novo Nordisk | 304.96B |
| UnitedHealth Group | 280.41B |
| Novartis AG | 235.85B |
| Abbott Laboratories | 233.80B |
| AstraZeneca | 217.42B |